Ilaria Priano
Meldola, 47014, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.
Journal: Genome medicine
Published: November 07, 2025
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival.
Journal: Lung Cancer (Auckland, N.Z.)
Published: August 24, 2024
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: September 25, 2023
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC.
Journal: Molecular oncology
Published: December 16, 2022
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Journal: Cancers
Published: August 05, 2022
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population.
Journal: Frontiers in oncology
Published: June 13, 2022
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis.
Journal: Frontiers in immunology
Published: January 31, 2022
Last Updated: 09/26/2026